Trinity Biotech plc

NASDAQ:TRIB

Medical - Diagnostics & Research

Healthcare
$5.83 -5.73%

-$0.51 today

Market cap
$117.96M
Beta
1.00
P/E (TTM)
-0.1
EPS (TTM)
-$60.27
52W Low $8.00High $103.20

Volume 0.00M

Average 1.34M

TRIB Net Change in Cash

Combined operating, investing, financing, and currency effects on the cash balance during the period.

Trinity Biotech plcNASDAQ: TRIB

Net Change in Cash · Q4 FY2025 · quarter ended Dec 2025

Net change in cash growth accelerates

Q4 FY2025 net change in cash of $3.8M rose 63.2% year over year, ahead of the -102.0% change in trailing-twelve-month net change in cash. Over 3 fiscal years it compounded at -88.6% a year.

Context

  • Net change in cash amounted to 0.1% of revenue in FY2025, down 2.3 pp from a year earlier.
  • Net change in cash increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +63.2% holds above the trailing-twelve-month pace of -102.0%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterDec 2025
$3.8M+1952.2% QoQ
Last fiscal yearDec 2025
-$29K-102.0% YoY
LTMDec 2025
-$29K-102.0% YoY
Net Change in Cash past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+63.2%——
1 year-102.0%——
3-year CAGR-88.6%——
5-year CAGR——
10-year CAGR——

Net Change in Cash history

USD · from the cash flow

Latest · FY2025
(29K) USD
Year-over-year change
-102.0%

Net Change in Cash vs competitors

How TRIB compares with its peers on the latest reported figures

No competitor Net Change in Cash figures are available to compare.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income875K(41.01M)(24.02M)(31.79M)(37.38M)
Depreciation & Amortization2.74M2.33M1.78M1.87M2.68M
Deferred Income Tax(167K)(192K)(59K)486K199K
Stock-Based Compensation1.1M1.76M2.07M1.32M324K
Change in Working Capital(172K)(1.66M)(2.69M)6.19M7.03M
Accounts Receivables6.24M(966K)1.05M(2.37M)4.92M
Inventory(4.41M)(877K)(971K)(1.74M)90K
Accounts Payables(7.59M)181K(2.77M)8.19M0
Other Working Capital5.59M7.57M(478K)10.3M2.02M
Other Non-Cash Items8.86M37.85M11.37M17.74M21.21M
Operating Cash Flow13.24M(921K)(11.56M)(4.19M)(5.93M)
Capital Expenditures(8.69M)(5.98M)(803K)(10.06M)(6.22M)
Acquisitions (Net)0028.16M(12.9M)0
Purchases of Investments00(700K)00
Sales of Investments00000
Other Investing Activities(6.88M)(4.88M)(1.9M)(9.66M)(6.14M)
Investing Cash Flow(8.69M)(5.98M)24.76M(22.97M)(6.22M)
Debt Repayment(2.94M)(27.04M)(7.37M)27.67M11.81M
Common Stock Issued025.34M07.39M547K
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(3.08M)(10.61M)(8.67M)(6.25M)(308K)
Financing Cash Flow(6.02M)(12.32M)(16.04M)28.81M12.05M
Effect of Forex Changes55K(112K)(44K)(175K)71K
Net Change in Cash(1.42M)(19.33M)(2.89M)1.48M(29K)
Free Cash Flow4.55M(6.9M)(12.36M)(14.26M)(12.15M)

Trinity Biotech plc

NASDAQ:TRIB

Intrinsic Alpha fair value

Locked

Current Price

$5.83

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.